APP and Alzheimer disease: Evidence has shown that some microRNAs may inhibit amyloid production at the genetic level, among which miR-29 and miR-101 were negatively correlated with the protein expression of APP and BACE1 [20, 21], providing a new direction for revealing the mechanism of moxibustion in the treatment of AD.